Precision Medicine Podcast · Trapelo

New Series: Bringing Precision Medicine to Everyone with Dr. Kashyap Patel + Dr. Angella Charnot-Katsikas

·34 min·2 clips
Dr. Patel names provider awareness, financial barriers, and payer policies as the three biggest obstacles.
Karen Cushman opens Season 6 with a series built around bringing precision medicine to everyone. She lays out the stakes clearly, pointing to rising cancer incidence, especially in some common cancers and among younger adults, and to the fact that the United States surpassed 2 million new cancer cases in 2024. The episode presents precision medicine as standard of care in national guidelines, not as some far-off ideal. It also makes the access problem hard to miss, especially in community settings where 80% of patients receive care. Gaps in testing and limited access to targeted therapies mean too many people still miss personalized care that could support better, earlier decisions and help save lives. Working with Dr. Kashyap Patel, the episode shifts from the promise of precision medicine to the harder work of putting it into practice. A patient story gives the point real weight: Patel describes helping a family with limited resources secure patient assistance support, and he uses the outcome as a clear example of what access can make possible. From there, the conversation widens into the barriers that keep those outcomes from becoming routine. Patel names provider awareness as the first obstacle, noting that even large teaching hospitals can miss the latest testing pathways. He then points to financial barriers, explaining that uninsured patients may not be able to absorb the cost of expensive testing. The third barrier is payer policy, which can vary by geography and by plan, leaving access uneven even when the clinical case is straightforward. The tone stays measured and collaborative throughout. The episode keeps returning to the same practical goal: more people should have access to testing, family counseling, germline testing, and precision medicine implementation that helps them make better decisions earlier. The closing note reinforces that this is ongoing work the field has to keep doing. The result is a grounded, advocacy-minded launch for a series centered on access.

As heard by us

A measured look at how precision medicine still runs into access gaps.

Precision medicine is treated less as a breakthrough story than as an access question: who gets tested, who gets counseling, and who reaches the right therapy in time. Karen Cushman opens a new series with Dr.

Read the full review in PlayNext →

Why you'd press play

You want the access barriers behind precision medicine, not just the science.

Read the full recommendation in PlayNext →
Listen to the show on